(Q34669942)
Statements
1 reference
A randomized study of the relative pharmacokinetics, pharmacodynamics, and safety of alirocumab, a fully human monoclonal antibody to PCSK9, after single subcutaneous administration at three different injection sites in healthy subjects (English)
1 reference
Catherine Lunven
1 reference
Tobias Paehler
1 reference
Franck Poitiers
1 reference
Aurélie Brunet
1 reference
Jacques Rey
1 reference
Corinne Hanotin
1 reference
William J Sasiela
1 reference
1 December 2014
1 reference
1 reference
32
1 reference
6
1 reference
297-301
1 reference
Identifiers
1 reference
1 reference
1 reference